Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 15, 2026
Date Accepted: Sep 29, 2026
Developing a stakeholder-informed Quality Use of Medicines analytics dashboard for acute mental health care: A cross-country protocol
ABSTRACT
Background:
Digital transformation of health systems is occurring accelerating globally across both high-income and low- and middle-income countries, creating new opportunities for data-driven care improvement. Mental health conditions affect approximately 20% of the populations in both Indonesia and Australia. Ensuring medicines are used safely and effectively, or the Quality Use of Medicines (QUM) is critical in mental health care, where treatment frequently involves long-term and potentially complex medicines.
Objective:
To use electronic medical records (EMR) in Indonesia and Australia to improve medicine use in acute mental health care and inform policy and practice, enabling shared learning across different health system contexts.
Methods:
The study will be conducted in parallel across both countries over 2024–2026, comprising four phases: (i) Identification, (ii) Reconciliation, (iii) Translation, and (iv) Validation. A co-design approach will be applied throughout, involving people with lived experience of mental illness, clinicians, policymakers, and health informaticians through focus groups and stakeholder consultations.
Results:
The project was funded by the Australian Government Department of Foreign Affairs and Trade through the Knowledge Partnership Platform Australia–Indonesia (KONEKSI) in June of 2024, with project activities commencing in August of 2024. To date, two clinicians focus group meetings and consumer focus groups involving stakeholders across Australia and Indonesia have been completed. A scoping review examining quality use of medicines in acute mental health settings has also been completed. Findings from these activities have informed data mapping and the identification of preliminary dashboard indicators. Analysis of stakeholder consultation data has been completed, with dissemination activities currently underway. The project is currently progressing to dashboard development and refinement, with ongoing stakeholder engagement and knowledge translation activities planned to support future implementation and evaluation.
Conclusions:
The study contributes to public health by improving the safety, effectiveness, and equity of mental health care through enhanced medicines management. By developing EMR-based, data-driven quality indicators and analytics tools, it supports continuous quality improvement and generates transferable insights to inform policy and practice across diverse health systems. Clinical Trial: Scoping review registered with PROSPERO (CRD42024583426)
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.